4/A: Twist Bioscience Executive Sells Shares to Cover Tax Obligations

A Twist Bioscience executive sold 1,811 shares to cover tax obligations related to vesting performance stock units.

Summary

• Dennis Cho, an officer at Twist Bioscience, sold 1,811 shares of common stock on November 6, 2024, at a price of $44.605 per share.
• The sale was to cover tax withholding obligations associated with the vesting of Performance Stock Units (PSUs).
• This transaction was not a discretionary trade by the reporting person but was mandated by the issuer's equity incentive plans.
• Following the transaction, Dennis Cho beneficially owns 92,670 shares of Twist Bioscience stock.
• This is an amended filing to correct a footnote from the original filing on November 8, 2024.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, which is common in publicly traded companies. It does not indicate any specific trend or issue within the biotechnology industry.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly traded companies, including those in the biotechnology sector.
• Similar transactions are regularly reported by executives at companies like Illumina, Pacific Biosciences, and Bio-Rad Laboratories, reflecting the common use of equity-based compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Twist Bioscience, stock sale, insider trading, tax obligations, performance stock units, equity incentive plans, Form 4, Dennis Cho